Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

NCT02081755 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

336

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: Everolimus
DRUG: Tacrolimus
DRUG: Myfortic
DRUG: CellCept
DRUG: Imuran

Sponsor

Baylor Research Institute